Anti-inflammatory effects of the selective phosphodiesterase 3 inhibitor, cilostazol, and antioxidants, enzymatically-modified isoquercitrin and alpha-lipoic acid, reduce dextran sulphate sodium-induced colorectal mucosal injury in mice

作者：Kangawa Yumi; Yoshida Toshinori^*; Abe Hajime; Seto Yoshiki; Miyashita Taishi; Nakamura Michi; Kihara Tohru; Hayashi Shim mo; Shibutani Makoto

来源：Experimental and Toxicologic Pathology, 2017, 69(4): 179-186.

DOI：10.1016/j.etp.2016.12.004

• Cilostazol
• Enzymatically modified isoquercitrin
• alpha-lipoic acid
• Interleukin-6
• Tumour necrosis factor -alpha
• Colitis

Developing effective treatments and preventing inflammatory bowel disease (IBD) are urgent challenges in improving patients' health. It has been suggested that platelet activation and reactive oxidative species generation are involved in the pathogenesis of IBD. We examined the inhibitory effects of a selective phosphodiesterase-3 inhibitor, cilostazol (CZ), and two antioxidants, enzymatically modified isoquercitrin (EMIQ) and alpha-lipoic acid (ALA), against dextran sulphate sodium (DSS)-induced colitis. BALB/c mice were treated with 0.3% CZ, 1.5% EMIQ and 0.2% ALA in their feed. Colitis was induced by administering 5% DSS in drinking water for 8 days. The inhibitory effects of these substances were evaluated by measuring relevant clinical symptoms (faecal blood, diarrhoea, and body weight loss), colon length, plasma cytokine and chemokine levels, whole genome gene expression, and histopathology. Diarrhoea was suppressed by each treatment, while CZ prevented shortening of the colon length. All treatment groups exhibited decreased plasma levels of interleukin (IL)-6 and tumour necrosis factor (TNF)-alpha compared with the DSS group. Microarray analysis showed that cell adhesion, cytoskeleton regulation, cell proliferation, and apoptosis, which might be related to inflammatory cell infiltration and mucosal healing, were affected in all the groups. DSS-induced mucosal injuries such as mucosal loss, submucosal oedema, and inflammatory cell infiltration in the distal colon were prevented by CZ or antioxidant treatment. These results suggest that anti-inflammatory effects of these agents reduced DSS-induced mucosal injuries in mice and, therefore, may provide therapeutic benefits in IBD.

• 出版日期2017-4